# DESCRIPTION

## BACKGROUND

## SUMMARY

## DETAILED DESCRIPTION

### Combination Compositions and Treatments

### Administration of the Bithionol Composition

## EXAMPLES

### Example 1. Identification of Host Hub Proteins Exploited by Multiple Pathogenic Toxins

### Example 2. The Effect of Caspase Mutations on the Sensitivity of Human B-Cells to P. aeruginosa Exotoxin A

### Example 3. A Multiplexed Cellular Screen for CCL Drugs that Inhibit Cytotoxic Activities of Bacterial Toxins Exploiting Unique but Interconnected Host Pathways

### Example 4. A Multiplex Protein Function-Based Screen for CCL Drugs that Inhibit Proteolytic Activities of Host Caspase-3, -6, and -7

### Example 5. Bithionol Reduces the Pathogenicity of a Range of Toxins by Inhibiting Host Caspases

### Example 6. Bithionol Inhibits Cytotoxic Activity of Anthrax Toxins

### Example 7. Bithionol Inhibits Ricin and Botulinum Neurotoxin A-Induced Death In Vitro and In Vivo

### Example 8. Bithionol Acts as a Zika Virus Inhibitor

### Example 9. Material and Methods

